Amrutanjan Health Care590006Board meeting scheduled

Board meeting on 3 November 2026 to consider Q2/H1 results and 1st interim dividend

Board meeting on Tuesday, 3 November 2026, through video conferencing.

By ScoutQuest · Tue 27 Oct 2026, 3:46 PM IST · 1 min read

Amrutanjan Health Care has informed the stock exchanges that its Board of Directors will meet on Tuesday, 3 November 2026 through video conferencing.

To consider and approve, inter-alia, the unaudited financial results for the quarter and half year ended 30 September 2026, along with the Limited Review Report of the statutory auditors.
Declaration of the 1st interim dividend for the financial year 2026-27.

Unaudited results are the company's numbers for the period, prepared but not yet fully audited. The Limited Review Report is the statutory auditors' comment that they have reviewed these numbers, which is the standard check for quarterly and half-yearly results of listed companies.
An interim dividend is a dividend paid during the financial year, before the final dividend for that year is decided. It is the first such interim dividend being taken up for the current financial year, 2026-27.

As already informed by the company's letter dated 25 September 2026, the trading window for dealing in the company's equity shares is closed from 1 October 2026 and will remain closed till 5 November 2026 under the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct.
A trading window closure applies to insiders, such as directors, designated employees and connected persons, around the time results are prepared and announced. It is a routine, periodic restriction.

The board meeting is where the results and the interim dividend are taken up. The dividend amount, if declared, and the results themselves would come to shareholders after that meeting. Until then, this letter only sets out the agenda for the meeting.

Also from Amrutanjan Health Care

3 Nov 2026

3 Nov 2026

9 Oct 2026